Lorcaserin
Predictors of Lorcaserin-Induced Weight Loss
Novo Nordisk · Phase 4 · Terminated · Enrollment 32
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Arm A | n/r | n/r | n/r | n/r |
| Arm B | n/r | n/r | n/r | n/r |
Not shown
- Arm A: endpoint not reported
- Arm B: endpoint not reported